Evidence map›Paper›PMID 22390356›Full record

ArticleBMC medical informatics and decision making2012

Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer.

Charlotte J Verberne, Cornelis H Nijboer, Geertruida H de Bock, Irene Grossmann, Theo Wiggers, Klaas Havenga

Abstract readEvaluation Study
In one paragraph

Article in BMC medical informatics and decision making, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer.International journal of clinical and experimental pathology · 2015
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charlotte J VerberneDepartment of Surgery, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands. c.j.verberne@umcg.nl
Cornelis H Nijboer
Geertruida H de Bock
Irene Grossmann
Theo Wiggers
Klaas Havenga

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe present paper is a first evaluation of the use of "CEAwatch", a clinical support software system for surgeons for the follow-up of colorectal cancer (CRC) patients. This system gathers Carcino-Embryonic Antigen (CEA) values and automatically returns a recommendation based on the latest values.

methodsConsecutive patients receiving follow-up care for CRC fulfilling our in- and exclusion criteria were identified to participate in this study. From August 2008, when the software was introduced, patients were asked to undergo the software-supported follow-up. Safety of the follow-up, experiences of working with the software, and technical issues were analyzed.

results245 patients were identified. The software-supported group contained 184 patients; the control group contained 61 patients. The software was safe in finding the same amount of recurrent disease with fewer outpatient visits, and revealed few technical problems. Clinicians experienced a decrease in follow-up workload of up to 50% with high adherence to the follow-up scheme.

conclusionCEAwatch is an efficient software tool helping clinicians working with large numbers of follow-up patients. The number of outpatient visits can safely be reduced, thus significantly decreasing workload for clinicians.

Indexed as

Decision Support Systems, ClinicalSoftwareAdultAgedAged, 80 and overCarcinoembryonic AntigenColorectal NeoplasmsFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm MetastasisNeoplasm Recurrence, LocalOutcome Assessment, Health CareReference ValuesCarcinoembryonic Antigen

Identifiers

PMID22390356
PMCPMC3330015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.